These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22854528)
21. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854 [TBL] [Abstract][Full Text] [Related]
22. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
23. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery. Kitrou P; Karnabatidis D; Katsanos K J Cardiovasc Surg (Torino); 2016 Aug; 57(4):569-77. PubMed ID: 27128105 [TBL] [Abstract][Full Text] [Related]
30. Drug-coated balloons--the importance of packing and dosing antiproliferative drugs. Hehrlein C Catheter Cardiovasc Interv; 2015 Aug; 86(2):287-8. PubMed ID: 26198065 [TBL] [Abstract][Full Text] [Related]
31. Drug-coated balloons in the lower limb. Zeller T; Schmitmeier S; Tepe G; Rastan A J Cardiovasc Surg (Torino); 2011 Apr; 52(2):235-43. PubMed ID: 21460774 [TBL] [Abstract][Full Text] [Related]
32. First use of drug-eluting balloon for below-the-elbow artery occlusion in a hemodialysis patient: a 3-year follow-up. Ferraresi R; Fattori SM; Cornacchiari M; Palloshi A J Vasc Access; 2013; 14(2):202-3. PubMed ID: 23032952 [No Abstract] [Full Text] [Related]
33. Commentary: Outback catheter in femoropopliteal subintimal angioplasty: new horizons in treating chronic total occlusions. Setacci C; Sirignano P; Setacci F J Endovasc Ther; 2011 Feb; 18(1):22-4. PubMed ID: 21314344 [No Abstract] [Full Text] [Related]
34. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. Katsanos K; Karnabatidis D; Kitrou P; Spiliopoulos S; Christeas N; Siablis D J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894 [TBL] [Abstract][Full Text] [Related]
35. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. Tepe G; Zeller T; Albrecht T; Heller S; Schwarzwälder U; Beregi JP; Claussen CD; Oldenburg A; Scheller B; Speck U N Engl J Med; 2008 Feb; 358(7):689-99. PubMed ID: 18272892 [TBL] [Abstract][Full Text] [Related]
36. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis. Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527 [TBL] [Abstract][Full Text] [Related]
37. Peripheral applications of drug-coated balloons: past, present and future. Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325 [TBL] [Abstract][Full Text] [Related]
38. Treatment paradigms for the superficial femoral artery: are they a-changin? Scheinert D JACC Cardiovasc Interv; 2012 Mar; 5(3):339-40. PubMed ID: 22440501 [No Abstract] [Full Text] [Related]
39. Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions. Lichtenberg M; Korosoglou G J Cardiovasc Surg (Torino); 2019 Apr; 60(2):205-211. PubMed ID: 30650960 [TBL] [Abstract][Full Text] [Related]
40. What are the potential limitations of drug coated balloons and possible ways to overcome. Werk M J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]